{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:27:00Z","timestamp":1761920820858,"version":"build-2065373602"},"reference-count":20,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"unspecified","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,9,22]]},"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>\n                     <jats:italic>Helicobacter pylori (H. pylori)<\/jats:italic> is the most well-known risk factor for gastric cancer. At present, <jats:italic>H. pylori<\/jats:italic> shows varying levels of resistance to different treatments, leading to a lower rate of <jats:italic>H. pylori<\/jats:italic> eradication. The aim of this study is to evaluate the efficacy of polaprezinc-containing quadruple therapy (PQT) for the eradication of <jats:italic>H. pylori<\/jats:italic> infection and, thus, to provide more evidence to inform the clinical treatment of <jats:italic>H. pylori<\/jats:italic> infection in China.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>This is a single-centre, single-blind, non-inferiority, randomised controlled trial, enrolling 158 patients with <jats:italic>H. pylori<\/jats:italic> infection. Patients are randomised (1:1) to the two groups for a 14-day therapy. Treatment group: PQT (esomeprazole 20\u2009mg, amoxicillin 1\u2009g, clarithromycin 500\u2009mg, polaprezinc 75\u2009mg) two times per day; control group: bismuth-containing quadruple therapy (esomeprazole 20\u2009mg, amoxicillin 1\u2009g, clarithromycin 500\u2009mg, bismuth potassium citrate 220\u2009mg) two times per day. The primary outcome is the rate of <jats:italic>H. pylori<\/jats:italic> eradication. Secondary outcomes are the incidence of adverse events and the gastrointestinal microbiota distribution. The 16S ribosomal RNA (16S rRNA) next-generation sequencing (NGS) is used to evaluate the effect of two different therapies on the distribution of the gastrointestinal microbiota.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>This study was approved by the Ethics Committee of Sichuan Cancer Center &amp; Hospital (No. SCCHEC-02-2019-015). Any amendment to the research protocol will be submitted for ethical approval. All participants must provide informed consent. On completion, the results of the study will be published in the appropriate peer-reviewed journal.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>ChiCTR1900025800; preresults.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-037182","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T16:41:46Z","timestamp":1605631306000},"page":"e037182","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of quadruple regimen with polaprezinc for gastric <i>Helicobacter pylori<\/i> infection eradication: protocol for a single-centre, single-blind, non-inferiority, randomised clinical trial"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1600-9571","authenticated-orcid":false,"given":"Dingkun","family":"Wu","sequence":"first","affiliation":[{"name":"School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"Center for Cancer Prevention Research, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Jilin People's Hospital, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingyuan","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Cancer Prevention Research, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinwen","family":"Tan","sequence":"additional","affiliation":[{"name":"Center for Cancer Prevention Research, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[{"name":"Center for Cancer Prevention Research, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Chen","sequence":"additional","affiliation":[{"name":"West China School of Public Health\/West China Fourth Hospital, Sichuan University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cancer Epidemiology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Cancer Prevention and Treatment Office, Yanting Cancer Hospital, Mianyang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haidong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Cancer Prevention and Treatment Office, Yanting Cancer Hospital, Mianyang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Yuan","sequence":"additional","affiliation":[{"name":"Cancer Prevention and Treatment Office, Yanting Cancer Hospital, Mianyang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2736-4766","authenticated-orcid":false,"given":"Yuqian","family":"Zhao","sequence":"additional","affiliation":[{"name":"Center for Cancer Prevention Research, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for Cancer Prevention Research, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"Department of Cancer Epidemiology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"2025101810441784000_10.11.e037182.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)92719-8"},{"key":"2025101810441784000_10.11.e037182.2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.04.022"},{"key":"2025101810441784000_10.11.e037182.3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/apt.14561","article-title":"Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection","volume":"47","author":"Zamani","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2025101810441784000_10.11.e037182.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020542"},{"key":"2025101810441784000_10.11.e037182.5","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pathol.1.110304.100125"},{"key":"2025101810441784000_10.11.e037182.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1001110"},{"key":"2025101810441784000_10.11.e037182.7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00510.x"},{"key":"2025101810441784000_10.11.e037182.8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1998.00806.x"},{"key":"2025101810441784000_10.11.e037182.9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.11.2657"},{"key":"2025101810441784000_10.11.e037182.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2011.00912.x"},{"key":"2025101810441784000_10.11.e037182.11","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3181bb87f4"},{"key":"2025101810441784000_10.11.e037182.12","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku050"},{"key":"2025101810441784000_10.11.e037182.13","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2019-319696","article-title":"Effect of Helicobacter pylori on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer","volume":"69","author":"Guo","year":"2020","journal-title":"Gut"},{"key":"2025101810441784000_10.11.e037182.14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314205"},{"key":"2025101810441784000_10.11.e037182.15","first-page":"1","article-title":"Research progress of 16S rRNA sequencing technology in detection of intestinal flora","volume":"22","author":"Guo","year":"2019","journal-title":"Laboratory Sci"},{"key":"2025101810441784000_10.11.e037182.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176555","article-title":"16S rRNA gene sequencing and healthy reference ranges for 28 clinically relevant microbial taxa from the human gut microbiome","volume":"12","author":"Almonacid","year":"2017","journal-title":"PLoS One"},{"key":"2025101810441784000_10.11.e037182.17","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7525-6-12","article-title":"Reliability and validity of the gastrointestinal symptom rating scale (GSRS) and quality of life in reflux and dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study","volume":"6","author":"Kulich","year":"2008","journal-title":"Health Qual Life Outcomes"},{"key":"2025101810441784000_10.11.e037182.18","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312288"},{"key":"2025101810441784000_10.11.e037182.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60020-2"},{"key":"2025101810441784000_10.11.e037182.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0209-9"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-037182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:44:25Z","timestamp":1760809465000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-037182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,17]]},"published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1136\/bmjopen-2020-037182"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-037182","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}